Carbamazepine for schizophrenia

Leucht, Stefan, Kissling, Werner, McGrath, John J. and White, Paul (2007) Carbamazepine for schizophrenia. Cochrane Database Systematic Reviews, 3: 1-50. doi:10.1002/14651858.CD001258.pub2

Author Leucht, Stefan
Kissling, Werner
McGrath, John J.
White, Paul
Title Carbamazepine for schizophrenia
Journal name Cochrane Database Systematic Reviews   Check publisher's open access policy
ISSN 1469-493X
Publication date 2007-07-18
Year available 2007
Sub-type Critical review of research, literature review, critical commentary
DOI 10.1002/14651858.CD001258.pub2
Issue 3
Start page 1
End page 50
Total pages 50
Place of publication Oxford, United Kingdom
Publisher John Wiley and Sons
Language eng
Subject 321204 Mental Health
730211 Mental health
Abstract Many people with schizophrenia do not achieve a satisfactory treatment response with just antipsychotic drug treatment and various adjunct medications are used to promote additional response. The antiepileptic carbamazepine is one such drug
Keyword Schizophrenia
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Non-UQ

Document type: Journal Article
Sub-type: Critical review of research, literature review, critical commentary
Collections: ERA 2012 Admin Only
School of Medicine Publications
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 5 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 37 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Fri, 28 Mar 2008, 10:52:14 EST by Carmel Meir on behalf of School of Medicine